Active research programs continue to explore applications beyond weight management, including non-alcoholic steatohepatitis (NASH), heart failure with preserved ejection fraction, and obstructive sleep apnea reflecting the broad therapeutic potential of dual incretin receptor modulation
Thomas DA, OBrien S, Rytting M, Ravandi F, Jabbour E, Ferrajoli A, Estrov Z, Garcia-Manero G, Burger JA, Wierda W, Konopleva M, Andreeff M , Kornblau SM, Verstovsek S, Borthakur G, Kadia T, Garris R, Pemmaraju N, Daver N, Jain N, Cortes J, Kantarjian HM
During the run-in period, both arms initially treated with semaglutide only for 2 weeks (Sema
Wyman goes, Longo's setting it up
In fact, in each of these trials, excluding ELIXA, treatment with GLP-1RA was associated with a significant reduction in new-onset MA, which is a surrogate marker for CV and hard renal outcomes (Table 1) [11]
Freedom Researches BPC-157 60 Caps BPC 157, a pentadecapeptide comprised of 15 amino acids, originates from the body protection compound (BPC) initially found and extracted from human gastric juice